Psyched: Cybin’s Center Stage In Novel Psychedelics, Musk & Ramaswamy, Britney’s Memoirs And More
Cybin Officially Owns Small Pharma, Gets Three New International Patents Granted
Is A Tesla Model 3 ‘Sport’ Variant Coming? What A Hacker’s ‘Random Findings’ Reveal
Tesla's latest software update indicates the introduction of a "Sport" version for the refreshed Model 3 in addition to a "base" version.
Devon Energy Eyes Marathon Oil, Weighs Strategic Acquisitions To Boost US Shale Presence
Oil and gas player Devon Energy Corp (NYSE: DVN) is reportedly exploring potential acquisition opportunities to bolster its presence in the U.S.
Alternative Asset Manager Brookfield’s Diversification, Exploring UK Pension Insurance with Possible Acquisitions
Brookfield Corporation (NYSE: BN) and its affiliate Brookfield Reinsurance Ltd (NYSE: BNRE) are reportedly exploring the possibility of venturing into the U.K.'s pension insurance sector.
Bitcoin Eyes Best Session In Nearly 2 Months: Bulls Regain $28,000 Mark, Surpass 200-Day Average
Bitcoin (CRYPTO: BTC) is poised to deliver its strongest daily performance since the end of August, surging by more than 5% as of 04:30 p.m. ET on Monday.
Why Is Alzheimer’s Player Prothena Stock Trading Higher Today?
Prothena Corporation plc (NASDAQ: PRTA) is reportedly talking to advisors, potentially preparing for a sale.
Shutdown Averted, Treasury Yields Flirt With 5%, Strong Payrolls Add to Fed Tightening Risk: The Week In The Markets
Catch up on the week's market highlights, from government funding drama to surging Treasury yields and an unexpectedly strong jobs report.
Amgen’s Adcomm Meeting Paves Way To Launch Boost For Mirati Therapeutics’ Lung Cancer Drug: Analysts
According to a report on Thursday, French pharma company Sanofi SA (NASDAQ: SNY) is reportedly exploring a potential acquisition of cancer drugmaker Mirati Therapeutics Inc (NASDAQ: MRTX).
Is Cupertino’s Next Trick A USB-C-Powered Apple Pencil 3? iOS 17.1 Beta 2 Drops Clues
The discovery of a code reference within Apple's iOS 17.1 Beta 2 has sparked speculation about the potential development of an Apple Pencil 3 with USB-C charging support.
Novartis Mulls Divesting Some Assets Of Radiopharma Unit In Strategic Shift
Swiss pharmaceutical giant Novartis AG (NYSE: NVS) is reportedly contemplating selling sections of radiopharmaceuticals company Advanced Accelerator Applications to align with the company's strategy and the broader industry trend to shed low-growth segments.